Estrella Immunopharma Inc (ESLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 06-2024 | 06-2023 | 12-2022 | |
| Operating Expenses | 13,063 | 4,427 | 7,310 | 11,114 | 1,570 |
| Operating Income | -13,063 | -4,427 | -7,310 | -11,114 | -1,570 |
| Other Income | 0 | 0 | 0 | 0 | 654 |
| Pre-tax Income | -13,063 | -4,427 | -7,310 | -11,114 | -916 |
| Income Tax | -1 | 0 | 2 | N/A | 81 |
| Net Income Continuous | -13,062 | -4,427 | -7,312 | -11,114 | -996 |
| Net Income | $-13,064 | $-4,427 | $-7,312 | $-11,114 | $-996 |
| EPS Basic Total Ops | -0.35 | -0.12 | -0.27 | -36.35 | -0.22 |
| EPS Basic Continuous Ops | -0.35 | -0.12 | -0.27 | -36.35 | -0.70 |
| EPS Diluted Total Ops | -0.35 | -0.12 | -0.27 | -36.35 | -0.22 |
| EPS Diluted Continuous Ops | -0.35 | -0.12 | -0.27 | -36.35 | -0.70 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.27 | N/A | N/A | N/A |
| EBITDA(a) | $-13,063 | $-4,427 | $-7,310 | $-11,114 | $-1,570 |